No beneficial effect of intrathecal methylprednisolone acetate in postherpetic neuralgia patients.

@article{Rijsdijk2013NoBE,
  title={No beneficial effect of intrathecal methylprednisolone acetate in postherpetic neuralgia patients.},
  author={Mienke Rijsdijk and Albert J M van Wijck and P C W Willem Meulenhoff and Annemiek Kavelaars and Ingeborg van van der Tweel and Cor J. Kalkman},
  journal={European journal of pain},
  year={2013},
  volume={17 5},
  pages={
          714-23
        }
}
BACKGROUND High efficacy of intrathecal methylprednisolone acetate (MPA) with lidocaine has been reported in a large patient group suffering from intractable postherpetic neuralgia (PHN). Because the treatment effect was never independently confirmed and there are ongoing safety concerns, intrathecal MPA did not become standard care for intractable PHN. We report the results of a replication trial assessing pain relief and spinal cytokine/chemokine levels in PHN patients. METHODS The number… CONTINUE READING
Highly Cited
This paper has 25 citations. REVIEW CITATIONS
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Spine Injectables: What Is the Safest Cocktail?

AJR. American journal of roentgenology • 2016
View 1 Excerpt